IP Verse

Assay For Plasma Cell Associated Disease - EP3631452

The patent EP3631452 was granted to The Binding Site Group on Jul 13, 2022. The application was originally filed on May 23, 2018 under application number EP18728707A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3631452

THE BINDING SITE GROUP
Application Number
EP18728707A
Filing Date
May 23, 2018
Status
Granted And Under Opposition
Jun 10, 2022
Grant Date
Jul 13, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTSMar 31, 2023-ADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2015154052
INTERNATIONAL-SEARCH-REPORTWO2017053932
OPPOSITIONEP0336472
OPPOSITIONWO2006099481
OPPOSITIONWO2015154052
OPPOSITIONWO2017053932
OPPOSITIONWO2017144900

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- Nelson Leung ET AL, "Laboratory testing in monoclonal gammopathy of renal significance (MGRS)", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, DE, (20160101), vol. 54, no. 6, doi:10.1515/cclm-2015-0994, ISSN 1434-6621, XP055489108
OPPOSITION- GOLDBERG, M. et al., "Specific Interchain Cross-Linking of Antibodies Using Bismaleimides. Repression of Ligand Leakage in Immunoaffinity Chromatography", Bioconjugate Chem, (19910000), vol. 2, pages 275 - 280, XP055367595
OPPOSITION- LAVATELLI, F. et al., "Systemic amyloidoses and proteomics: The state of the art", EuPA Open Proteomics, (20160000), vol. 11, pages 4 - 10, XP093044436
OPPOSITION- New Scientific Company S.R.L., "Free Light Chains, Immage Nephelometric Kit - Urine", Instructions Manual, (20020708), pages 1 - 2, XP093113696
OPPOSITION- BERGEN III, R. et al., "Characterization of amyloidogenic immunoglobulin light chains directly from serum by on-line immunoaffinity isolation", Biomed. Chromatogr., (20040000), vol. 18, doi:10.1002/bmc.323, pages 191 - 201, XP002475944
OPPOSITION- LAVATELLI, F. et al., "A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum", Biochimica et Biophysica Acta, (20110000), vol. 1814, doi:10.1016/j.bbapap.2010.12.012, pages 409 - 419, XP028362369
OPPOSITION- KOHLHAGEN, M.C. et al., "Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry", Clinical Chemistry, (20160000), vol. 62, no. 10, doi:10.1373/clinchem.2015.253781, pages 1345 - 1352, XP055711926

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents